2 assets in Sphingolipidosis

Therapeutic assets addressing Sphingolipidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Busulfanum Sphingolipidosis	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cald Hr-D Sphingolipidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)